BIOMAT Database Logo BIOMAT Database Logo

[Immunologic potency of pregnancy associated alpha 2-glycoprotein (alpha 2-PAG)]. 1978

H W Bauer, and H Bohn, and W Ax

The suggestion that the pregnancy-associated alpha2-glycoprotein could depress the immune response was investigated using the modified electrophoretic mobility test. The presence of the glycoprotein, at physiological levels, significantly reduced the inhibition of the migration velocity of indicator cells in the electric field caused by the MSF. In the contrary alpha2-PAG-free serum had no effect in the test system. Therefore, it can be supposed that alpha2-PAG may have an immunoregulatory function within the immunological mechanism which protects the conceptus and malignant tumor.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D008263 Macrophage Migration-Inhibitory Factors Proteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. Macrophage Migration Inhibitory Factor,Migration Inhibition Factors, Macrophage,Macrophage Migration Inhibition Factors,Migration Inhibition Factor, Macrophage,Macrophage Migration Inhibitory Factors,Migration-Inhibitory Factors, Macrophage
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H W Bauer, and H Bohn, and W Ax
The pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG). A tumour marker?
February 1981, Klinische Wochenschrift,
H W Bauer, and H Bohn, and W Ax
Clinical and immunological significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG).
January 1982, Placenta. Supplement,
H W Bauer, and H Bohn, and W Ax
Deficiency of serum "pregnancy-associated" alpha 2-glycoprotein alpha 2-PAG): association with disease.
February 1986, Journal of clinical pathology,
H W Bauer, and H Bohn, and W Ax
[Pregnancy,-associated alpha 2-glycoprotein (alpha 2-PAG): a possible marker for tumor monitoring?].
August 1980, Onkologie,
H W Bauer, and H Bohn, and W Ax
Detection of mammary micrometastases by pregnancy-associated alpha 2-glycoprotein (PAG, alpha 2-PAG or PAM) and carcinoembryonic antigen (CEA).
May 1979, European journal of cancer,
H W Bauer, and H Bohn, and W Ax
Pregnancy-associated glycoprotein (alpha 2-PAG)--a possible marker in breast cancer?
October 1984, International journal of cancer,
H W Bauer, and H Bohn, and W Ax
Pregnancy-associated glycoprotein (alpha 2-PAG) in the sera of children with malignancies.
January 1979, Advances in experimental medicine and biology,
H W Bauer, and H Bohn, and W Ax
Immunohistochemical definition of antigenic determinants of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) using monoclonal antibodies.
April 1988, The Journal of pathology,
H W Bauer, and H Bohn, and W Ax
Detection of alpha 2-pregnancy associated-glycoprotein (alpha 2-PAG) in cultured human peripheral blood mononuclear cells.
November 1986, The Tokai journal of experimental and clinical medicine,
H W Bauer, and H Bohn, and W Ax
Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
September 1981, Biken journal,
Copied contents to your clipboard!